ABSTRACT Owing to the increase in the number of diseases affecting ducks and the demand for food safety by consumers, vaccination has become one of the factors that influence duck meat productivity. The highly pathogenic avian influenza (HPAI) virus is one of the most prevalent and causes one of the most lethal diseases in domestic ducks, and Salmonella enterica serovar Typhimurium is a food-borne pathogen persistent in the domestic duck population. To better understand the optimal usage of HPAI and S. enterica serovar Typhimurium vaccines, we aimed to determine antigen dose, oil and gel adjuvant usage with prime-boost regimen, and vaccination age, inducing the best immune response in ducks, without an effect on body weight gain. In the case of the inactivated H5N9 vaccine, a single dose of vaccine was inadequate to induce proper antibody titer when administered to day-old ducks, which necessitates boost vaccination.
INTRODUCTION
Duck meat has traditionally been a major source of animal protein in many Asian countries. World production was approximately 4.4 million tons in 2013; this may exceed 4.5 million tons in 2015. Duck meat production in Asia increased by 40% between 2000 and 2010, greater than the increase observed in the production of other poultry species (www.fao.org; www.thepoultrysite.com). Under these circumstances, intensification and magnification of duck production seems to be the trend, similar to that in the chicken industry. However, traditional backyard or open house raising system is still widespread in Asia. No matter what raising system is applied, efficiency is the key element to making profit. Several factors help achieve C 2017 Poultry Science Association Inc. Received January 25, 2017. Accepted May 17, 2017. 1 Corresponding author: songcs@konkuk.ac.kr maximum efficiency, such as feed, cage, temperature, light, and genetic properties (Onbasilar et al., 2011; Campbell et al., 2015; Lin et al., 2016) . Recently, increases in the prevalence of duck diseases and demand for food safety has emphasized the role of vaccines as a factor influencing meat productivity. An optimal immune response to vaccines can clearly protect the ducks from infections. We also need to focus on the changes in body weight caused by inflammation in response to vaccination.
Since the H5N1 highly pathogenic avian influenza (HPAI) virus emerged in southern China in 1996, outbreaks have been reported in migrating and domestic ducks worldwide (Webster et al., 2006) . Moreover, because of the widespread infection of waterfowls with HPAI virus in Asian countries, including China, Vietnam, and Indonesia, it is essential to reduce the risk of virus infection in domestic ducks for controlling the spread of H5N1 HPAI (Pantin-Jackwood and Suarez, 2013 (Swayne et al., 2014) .
Ducks also serve as a reservoir of Salmonella enterica serovar Typhimurium, which is one of the common sources of human infections. Previous studies suggested that the serovar Typhimurium from ducks has been recorded from many countries including Egypt (Osman et al., 2014) , South Korea (Bae et al., 2013) , Malaya (Jamali et al., 2014) , Vietnam (Ogasawara et al., 2008) , United Kingdom (Little et al., 2008) , Taiwan (Tsai and Hsiang, 2005) and China (Tang et al., 2015) . In addition, distinct epidemic-causing clones have been found in ducks, and are considered a source of human infections (Rabsch et al., 2002) . When compared to the chicken industry, there have been limited attempts to control Salmonella enterica in domestic ducks, with competitive exclusion or antibiotic therapy (Barrow et al., 1999) . However, as the duck-meat industries increase, food safety issues mandate an effort towardvaccine development (Tang et al., 2015; Youn et al., 2016) .
The objective of this study was to determine whether a 1-or 2-dose regimen of the inactivated H5N9 HPAI vaccine and S. enterica serovar Typhimurium vaccine could enhance the antibody response in relation to the weight change caused by vaccination. We compared the efficiency of gel and oil adjuvants for optimizing effective vaccination strategies in domestic ducks. In terms of meat producing, we observed the effect of vaccination on weight so as to maximize the weight gain.
MATERIALS AND METHODS

Vaccine Preparation
The reverse genetics-derived H5N9 virus with the H5 HA gene modified by the deletion of nucleotides at the cleavage site between the HA1 and HA2 of H5N1 HPAI (A/mandarin duck/Korea/K10-483/2010) and N9 NA gene segments of low-pathogenic avian influenza virus H11N9 (A/wild bird/Korea/ENV13-36/2013) on a H1N1 backbone (A/Puerto Rico/8/1934) was generated, as described previously (Lee et al., 2004) . The rescued virus was replicated at 37
• C for 3 d in specific pathogen-free embryonated chicken eggs (SPF-ECE) and titered in SPF-ECE to obtain the 50% egg infectious dose (EID 50 ) of propagated viruses. The viruses were inactivated with 0.2% formalin for 24 h at room temperature, and diluted with PBS in consideration of antigen-oil adjuvant and antigen-gel adjuvant ratio to make the final titers as indicated in Table 1 . The water-in-oil emulsion was formulated by mixing the diluted antigen with Montanide ISA70 adjuvant (SEPPIC, France) at a ratio of 30:70 (v/v). The aluminum hydroxide gel-adjuvanted vaccine was formulated by mixing the diluted antigen with Rehydrogel LV (General Chemical, USA) at a ratio of 3:1 (v/v). The serovar Typhimurium vaccine was prepared using the ST26 strain, as described previously (Youn et al., 2016) . Briefly, the ST26 strain was provided by Dr. Kang in the national Quarantine and Inspection Agency and aerobically cultured in trypticase soy broth at 37
• C for 8 h with shaking (200 rpm). The culture was titered in trypticase soy agar to determine the colony-forming units (CFUs) and was inactivated by the addition of 0.5% formalin at 37
• C for 24 h with shaking. To make one dose of vaccine as indicated in Table 1 , the inactivated ST26 was diluted with PBS in consideration of antigen-oil adjuvant and antigen-gel adjuvant ratio. The inactivated culture was washed 3 times in sterile phosphate-buffered saline (PBS), and then, the diluted antigen was mixed with oil or gel adjuvant, as described above.
Experiment 1: Optimization of Inactivated H5N9 HPAI Vaccine in Domestic Ducks
All animal experiments conducted in this study were approved by the Institutional Animal Care and Use Committee (IACUC) of Konkuk University. Commercially available 260 day-old Pekin ducks, kindly provided by the Moran Food & Breeding Company (Eumseong, Republic of Korea), were housed and raised in the Biosafety Level 1 animal facility. All ducks were tagged individually and fed ad libitum. To confirm that ducks were serologically naïve, we utilized a commercially available competitive ELISA kit (AIV Ab ELISA; Bionote, South Korea) directed at anti-nucleoprotein (NP) antibodies. One hundred twenty day-old ducks were randomly designated into 12 groups of 10 ducks each (Table 1) . For the prime vaccination of 60 dayold ducks, 0.3 mL of the oil-or gel-adjuvanted H5N9 vaccine was subcutaneously injected at high, moderate, and low doses (10 8 , 10 7 , and 10 6 EID 50 /bird). With boost vaccination, 0.3 mL of oil-adjuvanted H5N9 vaccine was administered 4 wk after priming. All ducks were bled and weighed for 3 wk following vaccination. The other 60 day-old ducks were reared for 2 wk, and they were divided as same as above and then 0.3 mL of oil-or gel-adjuvanted H5N9 vaccine was intramuscularly injected with 3 doses (10 8 , 10 7 , and 10 6 EID 50 /bird). With the prime-boost regimen, the ducks were bled and weighed every week except wk 4 following vaccination, when boost vaccinations were administered. With the vaccination at 2-week-old ducks, the ducks were bled and weighed every week until 7 wk old.
Experiment 2: Optimization of Salmonella Serovar Typhimurium Vaccine in Domestic Ducks
One hundred twenty day-old ducks were obtained and vaccinated following the same scheme used in Experiment 1. The ducks were checked by bacteriological examination of cloacal swabs to ensure that they were Salmonella-free and then examined for serum antibody, as described in the section describing serological examination. The vaccine doses were separated into 3 doses (10 9 , 10 8 , and 10 7 CFU/bird). Bleeding and weighing schedule were the same as that followed in Experiment 1. The remaining 20 ducks were used as mock control group for comparison of weight gain with the inactivated H5N9 or ST26 vaccinated groups.
Serological Examination
Hemagglutinin inhibition (HI) assay was performed as described previously (Yuk et al., 2015) . Briefly, serum samples were treated overnight with the receptor-destroying enzyme (Denka Seiken Co., JAPAN) at 37
• C to eliminate non-specific HI factors. Thereafter, 25 μL of PBS was added to each well of the 96-well plates, and 25 μL of serum was transferred and serially diluted 2-fold in PBS. Then, 4 hemagglutination units of reverse genetics-derived H5N9 virus were added, and the mixture was incubated for 30 min at room temperature. The plates were incubated for 30 min at room temperature after the addition of 25 μ L of 1% turkey erythrocytes. The HI endpoint titer was determined as the reciprocal of the highest serum dilution that completely inhibited hemagglutination. In the Typhimurium experiment, the antibody response in vaccinated ducks was measured by enzyme-linked immunosorbent assay (ELISA) using a commercial kit (BioChek, Gouda, Netherlands), according to the manufacturer's instructions.
Statistical Analysis
The results of HI assay and mean body weight determination were analyzed by 2-way analysis of variance (ANOVA) using Prims 5 (GraphPad Co., La Jolla, CA) for comparing antibody levels and weight changes. Readings with a P-value of < 0.05 were considered statistically significant.
RESULTS
According to the OIE Terrestrial Manual on avian influenza, the minimum HI serological titer in chickens should be 5log 2 to protect them from mortality, and >7log 2 to reduce the replication and shedding of the challenge virus (Swayne and Brown, 2015) . Meanwhile, correlation between HI titer and protection remain to be understood in duck species. There are a few Gel-(A) or oil-(B) adjuvanted H5N9 vaccine was subcutaneously injected at high, moderate, and low doses (10 8 , 10 7 , and 10 6 EID 50 /bird) in day-old ducks. In boost vaccination, oil adjuvant H5N9 vaccine was administered 4 wk after priming. HI assay was performed to measure the immune response elicited by H5N9 inactivated vaccine. In case of the ST29 Salmonella enterica serovar Typhimurium vaccine, gel (C) or oil (D) prime and gel boost regimen, as described above, were applied at different doses (10 9 , 10 8 , 10 7 CFU/bird). The values obtained using a commercial ELISA kit were expressed as generalized titers in response to the ST29 vaccine. The dotted line in graphs A and B indicates the minimum HI serological titer (5log 2 ) required in field birds to protect them from mortality, which applied to chickens as recommended in OIE terrestrial manual. The dotted line in graphs C and D indicate seroconversion in response to the ST29 vaccine over a titer of 654, according to the manufacturer's instructions. studies that we can infer the correlation from the virus challenge results, which shows that HI titer lower than 5log 2 could confer protection from lethal challenge in ducks (Kim et al., 2008; Pantin-Jackwood et al., 2016) . Therefore, further study should be needed to reveal the correlation between HI titer and protective efficacy in domestic ducks as in case of chicken which is recommended in OIE manual. In the prime-boost vaccination regimen for day-old ducks, only the high dose of vaccine could induce the protective HI titer (>5log 2 ) ( Figure 1A and B). However, when we compared the weight of 7-week-old ducks, the oil-oil adjuvant regimen showed significantly lower body weight than the group with gel-oil adjuvant regimen. This result suggested that although we could not observe significant differences in the body weight of 3-week-old ducks, the application of oil adjuvants in day-old ducks might cause weight loss in 7-week-old ducks that are usually used as meat (Table 1). Single vaccination with the high dose of oil adjuvant of 2-week-old ducks conferred the protective HI titer (Figure 2A) . However, body weight loss was observed after the use of oil adjuvant in 7-week-old ducks (Table 1) . When we compare the HI results of oil-adjuvanted vaccine executed at day-old ducks or 2-week-old ducks ( Figures 1B and 2A) , vaccination in day-old ducks with oil adjuvants is not efficient to induce HI titer than vaccination in 2-week-old ducks. Taken together, we could conclude that 10 8 dose with the gel-oil regimen would be a practical option without causing reduction of the weight gain.
Seroconversion in response to the ST26 vaccine was defined as the generalized titer over 654, according to the ELISA kit instructions. According to the OIE terrestrial manual on Salmonella, the vaccine potency test should relate to the efficacy of the vaccine in the target species, and suitable criteria should be applied for passing batches. In this study, as we used the same vaccine strain, adjuvant, and dose with previous study (Youn et al., 2016) , 10 8 CFU/bird dose was supposed to be effective in preventing shedding of the Salmonella from challenge. Therefore, we focused on the weight gain after vaccination with adjuvant and dose usage. Immune responses induced by the H5N9 inactivated vaccine and ST29 vaccine in 2-week-old domestic ducks. (A) Gel-or oiladjuvanted H5N9 vaccine was subcutaneously injected at high, moderate, and low doses (10 8 , 10 7 , and 10 6 EID 50 /bird) in 2-week-old domestic ducks. HI assay was performed to measure the immune response induced by the H5N9 inactivated vaccine. (B) Gel-or oil-adjuvanted ST29 vaccine was also subcutaneously injected at high, moderate, and low doses (10 9 , 10 8 , and 10 7 CFU/bird). The values obtained using a commercial ELISA kit were expressed as generalized titers in response to the ST29 vaccine. The dotted line in graph A indicates the minimum HI serological titer (5log 2 ) required in field birds to protect them from mortality, which applied to chickens as recommended in OIE terrestrial manual. The dotted line in graph B indicates seroconversion in response to the ST29 vaccine over a titer of 654, according to the manufacturer's instructions.
In the case of the prime-boost vaccination, the 7-weekold ducks on gel-oil and oil-oil regimens managed to reach the mean generalized titer over 654 irrespective of the vaccine dose ( Figure 1C and D) . In particular, a high dose of oil-adjuvanted vaccine, even in the case of day-old ducks, caused seroconversion at 2 wk after prime-boost vaccination. However, after boost vaccination, the gel-oil regimen tended to increase the mean titer, whereas the oil-oil regimen tended to decrease the mean titer after a radical surge. In terms of body weight increase, 10 9 dose of the gel-oil regimen and 10 9 and 10 8 doses of the oil-oil regimen decreased the mean body weight compared to the mock control. Taken together, we could conclude that 10 7 dose of the gel-oil regimen would be a practical option without causing reduction of the weight gain. A single vaccination in 2-week-old ducks showed a clear difference in the mean titers between the groups receiving two types of adjuvants as observed after prime-boost vaccination in dayold ducks ( Figure 2) . However, reduction of the weight gain observed with the oil adjuvant was significantly lower than that observed with the gel adjuvant, similar to the H5N9 vaccine (Table 1) .
DISCUSSION
Owing to its convenience and cost effectiveness, one of the desired properties of HPAI vaccine is a singledose vaccination that can confer protection from mortality and viral shedding. However, most situations require a minimum of 2 doses, which is not an exception in domestic ducks (Eggert and Swayne, 2010; Pfeiffer et al., 2010) . Moreover, most oil-adjuvanted vaccines produced for chickens might be inadequate in ducks to provide optimal immunity. Few vaccines may elicit increased immune response in ducks by using a immunopotentiator (Le et al., 2011; Lu et al., 2016) . Importantly, it should be noted that laboratorybased vaccine studies cannot completely simulate field conditions, and that in situ protection is reported to be less effective, thus necessitating booster vaccination (Swayne) . Our results suggested that single-dose vaccination is not adequate to induce the required antibody titer. In addition, day-old ducks were less responsive to inactivated H5N9 vaccine. This could be the reason for commercial inactivated vaccines attempting primeboost vaccination in combination with vectored vaccine (Steensels et al., 2009; Kilany et al., 2015) . Similar to this study, the previous duck studies also proved that a single vaccination did not increase the HI titer to an extent displayed in chickens. In this point of view, some other inactivated avian influenza vaccine studies resulting high HI titer in ducks with a single vaccination shows discrepancy between HI titers (Liu et al., 2011; Teng et al., 2015) . When compared to that in the other experiment wherein chickens were vaccinated according to the prime-boost regimen (Lee et al., 2011) , we did not find any differences in the antibody titer between the groups on gel-oil and oil-oil regimens. However, the use of oil adjuvant in day-old ducks is not appropriate with respect to body weight at the time of slaughtering meat ducks (6 to 7 wk old). This was also observed in the single-vaccination experiment, in which 2-week-old ducks were vaccinated with oil adjuvant.
For the inactivated ST29 vaccine, when using the gel adjuvant, seroconversion was not detected until 3 wk post vaccination, even in 2-week-old ducks. However, as we showed in a previous study, this low antibody titer could diminish bacterial replication in the internal organs as well as fecal shedding, which suggest that the serum antibodies are not only part of the host's protective mechanism against Salmonella (Youn et al., 2016) . Unlike the findings of the H5N9 vaccine experiment, gel-as well as oil-adjuvanted vaccines at high dose decreased the mean body weight in 7-week-old ducks. In this experiment, although we did not decrease the underlying cause of the weight loss observed in day-old ducks receiving the inactivated ST29 vaccine compared to that in those receiving the inactivated H5N9 vaccine as a gel-adjuvanted vaccine, it could be attributed to the excessive tissue reaction induced by the bacterin at the site of inoculation. This can cause weight loss or decrease in feed intake (Sandhu, 1979) . Thus, we could conclude that moderate or low dose of vaccines would be appropriate for day-old ducks receiving the gel-oil regimen in using the inactivated ST29 vaccine. Single vaccination with the oil adjuvant also affected the mean body weight of 7-week-old ducks, suggesting that the gel adjuvant is more suitable in terms of meat production.
In this study, we aimed to investigate the optimal antigen dose and adjuvant usage that can induce immune response without causing body weight loss. To the best of our knowledge, this is the first study to identify a relationship between the immune response to a viral or bacterial vaccine and body weight in domestic ducks. Although we did not attempt a challenge trial to study whether the optimal antigen dose and adjuvant defined by us will exert a protective effect after infection, the antibody titers noted as an index of vaccine-induced immune response were adequate to protect the ducks from infections. We expect that the use of adjuvants in a prime-boost regimen and the antigen dose set by this study would be helpful with respect to body weight in the production of ducks at the actual sites.
